Skip to main
CVRX
CVRX logo

CVRx (CVRX) Stock Forecast & Price Target

CVRx (CVRX) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 33%
Hold 0%
Sell 17%
Strong Sell 0%

Bulls say

CVRx has demonstrated a robust financial position, exiting Q3 with $100 million in cash, which management believes will support breakeven and facilitate growth initiatives leading into 2025. The company reported a remarkable median increase of 14 implants in the first nine months of 2024, signifying a growth rate of 92% compared to the previous year, indicating strong market demand for its Barostim technology. Additionally, recent positive reimbursement updates are expected to enhance the adoption and utilization of Barostim, further solidifying CVRx's position in an under-penetrated market with significant growth potential.

Bears say

CVRx reported Q3 revenue of $13.4 million, reflecting a 27% year-over-year growth, but the company's adjusted revenue guidance for 2024 fell by $500,000, indicating potential challenges ahead. The high cash burn rate of $9.8 million from operations during the quarter, along with a concentrated operational risk due to reliance on a single facility in Minneapolis, raises concerns about the company's financial stability and ability to meet growing operational demands. Additionally, the competitive landscape poses significant threats, as established medical device companies with greater resources may impact CVRx's market position and hinder long-term growth prospects.

CVRx (CVRX) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CVRx and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CVRx (CVRX) Forecast

Analysts have given CVRx (CVRX) a Buy based on their latest research and market trends.

According to 6 analysts, CVRx (CVRX) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CVRx (CVRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.